NCT04801485View on ClinicalTrials.gov

D-chiro Inositol in Prevention of Gestational Diabetes Mellitus in China

NACompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

May 1, 2023

Conditions
Gestational Diabetes Mellitus in Pregnancy
Interventions
DIETARY_SUPPLEMENT

D-chiro inositol

Active group receives inositol 1 gram per day as well as health guidance about diet and exercise. From recruitment until OGTT.

DIETARY_SUPPLEMENT

Placebo

Placebo (similar appearance but not containing myo-inositol) 1 gram per day before meals. Similar health guidance about diet and exercise. From recruitment until OGTT.

Trial Locations (1)

310000

Xinning Chen, Hangzhou

All Listed Sponsors
collaborator

Quzhou Maternal and Child Health Care Hospital

UNKNOWN

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER

NCT04801485 - D-chiro Inositol in Prevention of Gestational Diabetes Mellitus in China | Biotech Hunter | Biotech Hunter